Get started
Author

Manna Chang

OpenAlex ID: A5050597922
Intraoperative Fluorescence Guidance for Breast Cancer Lumpectomy Surgery
2023 · Barbara L. Smith, Kelly K. Hunt, et al. · NEJM Evidence · 62
Clinical Impact of Intraoperative Margin Assessment in Breast-Conserving Surgery With a Novel Pegulicianine Fluorescence–Guided System
2022 · E. Shelley Hwang, Peter Beitsch, et al. · JAMA Surgery · 50
PDF
Abstract PO5-22-09: Positive pegulicianine fluorescence rate in the lumpectomy cavity correlates with tumor distance to margins in excised tissue
2024 · Irene Wapnir, E Shelley Hwang, et al. · Cancer Research · 1
Abstract P1-20-06: Results from the expansion into multiple institutions for training in the use of the LUM imaging system for intraoperative detection of residual cancer in the tumor bed of female subjects with breast cancer clinical trial
2020 · Jorge Ferrer, David Carr, et al. · Cancer Research · 1
Abstract P5-09-13: LumiSystem-guided lumpectomy enables informed customization of radiation therapy in select patients with breast cancer
2025 · Simona Shaitelman, Roberto Diaz, et al. · Clinical Cancer Research
Abstract P3-09-04: Does additional margin excision during LumiSystem pegulicianine fluorescence-guided lumpectomy surgery affect patient breast satisfaction?
2025 · Abigail E Daly, Kyle J Anderman, et al. · Clinical Cancer Research
Abstract PO4-11-12: Patient Reported Outcomes from a multi-site, prospective Pivotal study evaluating pegulicianine fluorescence guided surgery (pFGS) for breast cancer lumpectomy procedures using the Lumicell Direct Visualization System (DVS)
2024 · Kelly Hunt, Irene Wapnir, et al. · Cancer Research
Abstract CT043: Feasibility study to evaluate performance of the LUM Imaging System for intraoperative detection of residual tumor in breast cancer patients receiving and not receiving neoadjuvant therapy
2023 · Jorge M. Ferrer, Irene Wapnir, et al. · Cancer Research
Abstract OT2-07-01: Feasibility study to evaluate performance of the LUM Imaging System for intraoperative detection of residual tumor in breast cancer patients receiving and not receiving neoadjuvant therapy
2023 · Irene L. Wapnir, Kelly K. Hunt, et al. · Cancer Research
Abstract OT2-12-02: Feasibility study to evaluate performance of the LUM imaging system for intraoperative detection of residual tumor in patients with breast cancer receiving neoadjuvant therapy
2022 · Kate P Smith, Jorge Ferrer, et al. · Cancer Research
Abstract OT2-12-03: Pivotal study of the Lum imaging system for assisting intraoperative detection of residual cancer in the tumor bed of female patients with breast cancer: The INCITE trial
2022 · Jorge Ferrer, David Carr, et al. · Cancer Research
Abstract CT259: Pivotal Study of the LUM Imaging System for assisting intraoperative detection of residual cancer in the tumor bed of female patients with breast cancer
2021 · Jorge Ferrer, David Carr, et al. · Cancer Research
Abstract CT245: Feasibility study to evaluate performance of the Lum Imaging System for intraoperative detection of residual tumor in patients with breast cancer receiving neoadjuvant therapy
2021 · Jorge Ferrer, Bridget Kelly, et al. · Cancer Research
Abstract CT281: Pivotal study of the LUM Imaging System for assisting intraoperative detection of residual cancer in the tumor bed of female patients with breast cancer
2020 · Jorge Ferrer, David Carr, et al. · Cancer Research
Mpth-36. Comprehensive Genomic Analysis of Young Adult Glioblastomas Reveals Four Subclasses With Distinct Driver Events
2016 · Shakti Ramkissoon, Manna Chang · Neuro-Oncology
PDF
Works count: 15
Citation count: 114
H-index: 2
I10-index: 2
Year
Topic
Type